Back to results
US 2004/0176413 A1Published application
Serotonin antagonists
AssigneeAventis Pharmaceuticals Inc.
InventorsThaddeus R. Nieduzak, Mark W. Dudley, John H. Kehne
Life of this patent
Estimating the term…
Abstract
The present invention is directed to a new class of serotonin 5HT2 antagonists and thier use in the treatment of a variety of diseases.
Claims18
A compound of the formula:
- 20
- in which R is represented by hydrogen, halogen, C1-4 alkyl, C1-4 alkoxy, —CF3, —OH, of —OCF3;
- and A is represented by one of the following imide derivatives:
- 21
- in which R1 and R2 are each independently represented by hydrogen, halogen, C1-4 alkyl, C1-4 alkoxy, —CF3, —OH, or —OCF3;
- and the pharmaceutically acceptable salts thereof.
3 more elements
Dependencies are inferred from the claim text.